{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:11:14Z","timestamp":1760616674596,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["171202002"],"award-info":[{"award-number":["171202002"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.rmed.2017.06.012","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T05:01:02Z","timestamp":1498021262000},"page":"145-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0626-4635","authenticated-orcid":false,"given":"Cornelis H.","family":"van Werkhoven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewoudt M.W.","family":"van de Garde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Jelrik","family":"Oosterheert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douwe F.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc J.M.","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.rmed.2017.06.012_bib1","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"issue":"Suppl 2","key":"10.1016\/j.rmed.2017.06.012_bib2","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2017.06.012_bib3","first-page":"90","article-title":"SWAB\/NVALT (Dutch working party on antibiotic policy and Dutch association of chest physicians) guidelines on the management of community-acquired pneumonia in adults","volume":"70","author":"Wiersinga","year":"2012","journal-title":"Neth J. Med."},{"issue":"Suppl 3","key":"10.1016\/j.rmed.2017.06.012_bib4","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1086\/591409","article-title":"Is activity against \u201catypical\u201d pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy","volume":"47","author":"Bartlett","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2017.06.012_bib5","first-page":"555","article-title":"How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review","volume":"52","author":"Oosterheert","year":"2003","journal-title":"JAntimicrobChemother"},{"issue":"2","key":"10.1016\/j.rmed.2017.06.012_bib6","doi-asserted-by":"crossref","first-page":"e006892","DOI":"10.1136\/bmjopen-2014-006892","article-title":"Antibiotic prescribing on admission to patients with pneumonia and prior outpatient antibiotic treatment: a cohort study on clinical outcome","volume":"5","author":"Van de Garde","year":"2015","journal-title":"BMJ Open"},{"issue":"14","key":"10.1016\/j.rmed.2017.06.012_bib7","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2017.06.012_bib8","first-page":"170","article-title":"Antibiotic treatment of moderate-severe community-acquired pneumonia: design and rationale of a multicentre cluster-randomised cross-over trial","volume":"72","author":"Van Werkhoven","year":"2014","journal-title":"Neth J. Med."},{"issue":"4","key":"10.1016\/j.rmed.2017.06.012_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A\u00a0prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"NEnglJMed"},{"key":"10.1016\/j.rmed.2017.06.012_bib10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","author":"Lim","year":"2003","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.rmed.2017.06.012_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/00365540410020091","article-title":"Comparative study of community-acquired pneumonia caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae","volume":"36","author":"Sopena","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2017.06.012_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00228-007-0407-0","article-title":"Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study","volume":"64","author":"Van de Garde","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.rmed.2017.06.012_bib13","doi-asserted-by":"crossref","first-page":"O531","DOI":"10.1111\/1469-0691.12524","article-title":"Impact of pre-hospital antibiotic use on community-acquired pneumonia","volume":"20","author":"Simonetti","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.rmed.2017.06.012_bib14","first-page":"118","article-title":"A\u00a0review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance","volume":"41","author":"Fuller","year":"2005","journal-title":"ClinInfectDis"},{"issue":"9560","key":"10.1016\/j.rmed.2017.06.012_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rmed.2017.06.012_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/11597870-000000000-00000","article-title":"Antimicrobial prescribing in hospitalized adults stratified by age: data from the ESAC point-prevalence surveys","volume":"29","author":"Zarb","year":"2012","journal-title":"Drugs Aging"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117301798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117301798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:39:33Z","timestamp":1760614773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611117301798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":16,"alternative-id":["S0954611117301798"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2017.06.012","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2017.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}